Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetylator phenotype. [electronic resource]
Producer: 20110908Description: 519-24 p. digitalISSN:- 0946-1965
- Acetylation
- Administration, Oral
- Adolescent
- Adult
- Antihypertensive Agents -- administration & dosage
- Case-Control Studies
- DNA Methylation -- drug effects
- Delayed-Action Preparations
- Dose-Response Relationship, Drug
- Female
- Humans
- Hydralazine -- administration & dosage
- Male
- Neoplasms -- drug therapy
- Phenotype
- Tablets
- Young Adult
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.